PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Schmidt, S.F. ; Rohm, M. ; Herzig, S. ; Berriel Diaz, M.

Cancer cachexia: More than skeletal muscle wasting.

Trends Cancer 4, 849-860 (2018)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Cancer cachexia is a multifactorial condition characterized by body weight loss that negatively affects quality of life and survival of patients with cancer. Despite the clinical relevance, there is currently no defined standard of care to effectively counteract cancer-associated progressive tissue wasting. Skeletal muscle atrophy represents the main manifestation of cancer cachexia. However, cancer cachexia is increasingly seen as a systemic phenomenon affecting and/or influenced by various organs. Here, we describe recent developments elucidating the roles of different tissues as well as tissue crosstalk in this wasting syndrome, including potential links to other cancer-associated morbidities. A more comprehensive understanding of cancer cachexia etiology and heterogeneity may enable the development of intervention strategies to prevent or reverse this devastating condition.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
7.038
1.146
53
81
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Acute-phase Response; Adipose Triglyceride Lipase; Gut Barrier Dysfunction; Necrosis-factor-alpha; Pancreatic-cancer; Metabolic Dysfunction; Therapeutic Target; Insulin-resistance; Anorexia-cachexia; Mononuclear-cells
Sprache englisch
Veröffentlichungsjahr 2018
HGF-Berichtsjahr 2018
ISSN (print) / ISBN 2405-8033
e-ISSN 2405-8025
Zeitschrift Trends in cancer
Quellenangaben Band: 4, Heft: 12, Seiten: 849-860 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Amsterdam
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Cancer (IDC)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-501900-253
G-501900-251
G-501900-257
DOI 10.1016/j.trecan.2018.10.001
WOS ID WOS:000450815300008
Scopus ID 85055264073
PubMed ID 30470306
Erfassungsdatum 2018-11-03
[➜Korrektur melden]